Etiophatogenesis of cutaneous T-cell lymphomas (mycosis fungoides/Sézary syndrome);Etiopatogenia de los linfomas cutáneos de células T (micosis fungoide/síndrome de sézary)

Actas Dermo-Sifiliograficas

Volumn 91, Issue 11, 2000, Pages 477-483

  De la Fuente, Enrique Gómez ^a   Pérez, Nuria Barrientos ^a   Ortiz Romero, Pablo L ^a   Álvarez Fernández, José G ^a   Sebastián, Fernández Francisco Vanaclocha ^a   Díez, Luis Iglesias ^a  

^a NONE

Author keywords

Cutuneous T cell lymphomas; Cytokines; Etiophatogenia; Major histocompatibility antigens; Oncogenes

Indexed keywords

EID: 0004780016     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Alibert JLM. Tableau de Pian Fongoide: description des maladies de la peau observée a l'hopital St. Lous et exposition des meilleures methods suivies pour leur traitement. Paris (France): Barrior L'Aine et Files; 1806. p. 157.
2. Bazin PAE, ed. Leçons sur le traitement des maladies chroniques. Paris: Adrian dela Haye; 1870. p. 425.
3. Edelson RL. Cutaneous T-cell lymphoma: mycosis fungoides, Sézary syndrome and other variants. J Am Acad Dermatol 1980;2:89-106.
4. Diamandidou E, Cohen PR, Kuzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996;88:2385-409.
5. Weinstock MA, Horn JW. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 1988;260:42-6.
6. Weinstock MA. Epidemiology of mycosis fungoides. Sem Dermatol 1994;13:154-9.
7. Weinstock MA, Gardstein BA. Twenty year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 1999;89:1240-44.
8. Jones GW, Wilson LD. The changing survival of patients with mycosis fungoides. A population-based assesment of trends in the United States. Cancer 1999;86:191-3.
9. Duncan K, Heald P. Cutaneous T-cell lymphoma: centuries of controversy. Semin Cut Med Surg 1998;17:133-40.
10. Veelken H, Wood GS, Sklar J. Molecular staging of cutaneous T-cell lymphoma. Evidences for systemic involvement in early disease. J Invest Dermatol 1995;104:889-4.
11. Much JM, Lukowsky A, Asadullah K, Gellrich S, Sterry W. Demonstration of frequent occurrence of clonal T cells in peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997;90:1636-42.
12. Sandbank M, Ketzenellenbeger I. Mycosis fungoides of prolonged duration in siblings. Arch Dermatol 1968;98:620-7.
13. Whittemore A, Holly E, Lee I, y cols. Mycosis fungoides in relation to environmental exposure and immune response: a case control study. J Natl Cancer Inst 1989;81:1560-7.
14. Tuyp E, Burgoyne A, Aitchinson T, MacKie R. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987;123:196-200.
15. Bachelez H, Gorochov G. More about T-cell receptor V-beta repertoire usable in mycosis fungoides/Sézary syndrome. Br J Dermatol 1995;132:1017-8.
16. Bahler DW, Berry G, Oksenberg J, Warnke RA, Levy R. Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. Am J Pathol 1992;140:1-8.
17. Kono DH, Baccala R, Balderas RS, y cols. Application of a multiprobe RNAsa protector assay on juntional sequences to define V-beta gene diversity in Sézary syndrome. Am J Pathol 1992;140:823-30.
18. McHenry PM, Campbell I, Mackie RM. Assessment of an anti T-cell receptor variable region antibody panel cutaneous T cell lymphomas. Br J Dermatol 1994;130:595-8.
19. Pancake BA, Zucker-Franklin D, Coutara EE. The cutaneous T-cell lymphoma, Mycosis fungoides is a human T-cell lymphotropic virus associated disease. A study of 50 patients. J Clin Invest 1995;95:547-54.
20. Zucker-Franklin D, Hooper Wc, Evatt BL. Human lymphotropic retroviruses associated with mycosis fungoides: evidence that HTLV type II as well as HTLV-1 may play a role in the disease. Blood 1992;80:1537-45.
21. Khan ZM, Seiboni KM, Zucker-Franklin D. Localization of human T-cell lymphotropic virus-I tax proviral sequences in skin biopsies of patients with mycosis fungoides by in situ polymerase chain reaction. J Invest Dermatol 1996;106:667-72.
22. Wood G, Salvekar A, Schaffer J, y cols. Evidence against role for HTLV-I in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol 1996;107:301-7.
23. Bazarbachi A, Soriano V, Pawson R, y cols. Mycosis fungoides and Sézary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol 1997;98:927-33.
24. Fujihara K, Goldman B, Oseroff AR, y cols. HTLV-associated diseases: human retroviral infection and cutaneous T-cell lymphomas. Immunol Invest 1997;26:231-42.
25. Allejo A, López JL, Ortiz PL, y cols. Is mycosis fungoides related to HTLV-I? Vox Sanguinis 1995;69:84.
26. Zucker FK, Pancake BA. Human T-cell lymphtropic virus type I tax among American blood donors. Clin Diagn Lab Immunol 1998;5:831-5.
27. Cowan EP, Nemo GJ, Williams AE, y cols. Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washintong, DC, area: results from a multicenter study. Transfusion 1999;39:904-9.
28. Dalekos GN, Zervou E, Karabini F, Elisaf M, Bourantas K, Siamopoulos KC. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in Nothwestern Greece. Transfusion 1995;35:503-6.
29. Zaaijer HL, Lelie PN, Van der Poel CL. Infection with T-lymphotropic virus in Dutch blood donors 1993-1996. Ned Tijdschr Geneeskd 1997;141:1571-2.
30. Duvic M, Magie K, Storthz KA. In situ hybridzation for herpes simplex virus in mycosis fungoides and alopecia areata. J Invest Dermatol 1989;92:423.
31. Brice SL, Jesler JD, Friednash M, y cols. Examination of cutaneous T-cell lymphoma for human herpes virus by using the polymerase chain reaction. J Cutan Pathol 1993;20:304.
32. Kanavaros P, Ioamidou D, Tzardi M, y cols. Mycosis fungoides expression of c-myc, p62, p53, bcl2 and PCNA proteins and absence of association with EB-v. Pathol Res Pract 1994;190:767-74.
33. Nahass GT, Kraffert CA, Penneys NS. Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome. Arch Dermatol 1991;127:1020.
34. Mackie R, Dick, HM, De Sousa MB. HLA and mycosis fungoides. Lancet 1976;1:1179.
35. Rosen S, Radvany R, Roenigk HJ, y cols. Human leukocyte antigens in cutaneous T-cell lymphomas. J Am Acad Dermatol 1985;12:531-4.
36. Ryder LP, Anderson L, Svejgaard A, eds. HLA and disease registry-Third report. Tissue antigens 1979;15(Supl. 1).
37. Safai B, Myskowski PL, Dupont B, y cols. Association of HLA DR5 with mycosis fungoides. J Invest Dermatol 1983;80:395.
38. Jackow CM, McHam JB, Friss A, Alvear J, Reveille JR, Duvic M. HLA-DR5 and DQB1*03 alleles are associated with cutaneous T-cell lymphoma. J Invest Dermatol 1996; 107:373-6.
39. Verga M, Braverman M. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis. Arch Dermatol 1991;127:1503-10.
40. Hansen ER. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma. Arch Dermatol 1996;132:554-61.
41. Bagot M, Wechsler J, Lescs MC. Intraepidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:589-95.
42. Fivensen DP, Hanson CA, Nickoloff BJ. Localization of clonal T cells in the epidermis in cutaneous T-cell lymphoma. J Am Acad Dermatol 1994;31:717-24.
43. Bagot M, Echchakir H, Mami-Chouaib F, y cols. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 1998;91:4331-41.
44. Shiohara T, Moriya N, Gotoh C, y cols. Differential expression of lymphocyte function associated antigen (LFA-1) on epidermotropic and non-epidermotropic T-cells clones. J Invest Dermatol 1989;93:804-8.
45. Pujol RM. Estudio inmunofenotípico y análisis genotípico en los linfomas cutáneos de células T (micosis fungoide/síndrome de Sezary), pseudolinfomas cutáneos T y erupciones cutáneas potencialmente prelinfomatosas. Tesis doctoral 1992.
46. Walsch LJ, Murphy GF. Role of adhesion molecules in cutaneous inflammation and neoplasia. J Cutan Pathol 1992;19:161-71.
47. Griffiths CE, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989;20:617-9.
48. Nickoloff BJ, Griffiths CE, Baadsgaard O, Voorhees JJ, Hanson CA, Cooper KD. Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sézary syndrome. JAMA 1989;261: 2217-21.
49. Sica A, Matsushima K, Van Damme J, y cols. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 1990;69:548-53.
50. Osborn L, Hession C, Tizard R, y cols. Direct expression cloning pf vascular cell adhesion molecule-1, a citokyneinduced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
51. Wasik MA, Vonderheid EC, Bigler RD, y cols. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Arch Dermatol 1996; 132: 42-7.
52. Zachariae C, Larse CS, Kaltoft K, y cols. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders. Acta Derm Venereol (Stockch) 1991;71:465-70.
53. Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th-1 type cell-mediated cytokine profile whereas Sézary syndrome expresses a Th2 type profile. J Invest Dermatol 1994;103:29-33.
54. Camp R, Bacon K, Finchan N, y cols. Chemotactic cytokines in inflammatory skin disease. Adv Exp Med Biol 1991;305:109-18.
55. Wismer ML, Mackenzie RC, Sauder D. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients. Lymphokine Cytokine Res 1994;13:21-7.
56. Asadullah K, Docke WD, Haeussler A. Sterry W, Volk HD. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. J Invest Dermatol 1996;107:833-7.
57. Rook AH, Kubin M, Cassin M, y cols. IL-12 reserves cytokine and immune abnormalities in Sézary syndrome. J Immunol 1995;154:1491-8.
58. Tensen CP, Vermeer MH, Van der Stoop PM, y cols. Epidermal interferon-gamma inducible. protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T-cell lymphomas. J Invest Dermatol 1998;11:222-6.
59. Dummer R, Heald PW, Nestle FO, y cols. Sézary syndrome T-cells clones display T-helper 2 cytokines and express the accesory factor-1 (interferon-γ receptor β-chain). Blood 1996; 88:1383-9.
60. Vowels BR, Lessin SR, Cassin M, y cols. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994;103:669-73.
61. Harwix S, Zachmann K, Neumann C. T-cells clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile. Arch Dermatol Res 2000;292:1-8.
62. Limon J, Nedoszytko B, Brozek I, y cols. Chromosome aberrations of five cases with Sézary syndrome. Cancer Genet Cytogenet 1995;83:75-81.
63. Shapiro PE, Warburton D, Berger CL, y cols. Clonal chromosomal abnormalities in cutaneous T-cell lymphoma. Cancer Genet Cytogenet 1987;28:267-76.
64. Kaltoft K, Holm-Hansen B, Therstrup-Pedersen K. Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol Clin 1994;12:295-304.
65. Kaltoft K, Bisballe S, Dyrberg T, y cols. Establishmet of two continuous cell strains from a single plaque of a patient with mycosis fungoides. In vitro Cell Dev 1992;28A:161.
66. McGrefor JM, Dublin EA, Levison DA, y cols. p53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 1995;132:353-8.
67. Scarisbrick JJ, Alison J, Woolford J, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma mid possible association with homozygous delection of PTEN. Blood 2000;95:2935-42.
68. Lauritzen AF, Vejlsgaard GJ, Hou-Jensen K, y cols. p53 protein expression in cutaneous T-cell lymphoma. Br J Dermatol 1995;133:32-6.
69. Garatti SA, Roscetti E, Treca D, Fracchiolla NS, Neri A, Berti E. bcl1, bcl2, p53, c-myc and lyt10 analysis in cutaneous lymphomas. Rec Res Cancer 1991;139:249-61.
70. Peter M, Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994;79:181-4.
71. INK4a. Exp Cell Res 1997;237:7-13.
72. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K. Deletions of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
73. Cairns P, Mao L, Merlo A, y cols. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-7.
74. Villuendas R, Sánchez-Beato M, Martínez JC, y cols. Loss of p16/INK4A protein expression in Non-Hodgkin's lymphomas is a frequent finding associated with tumor progresion. Am J Pathol 1998;153:887-97.
75. Elenitoba-Johnson KS, Gascoyne RD, Lim MS, Chanabai M, Jaffe ES, Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 4677-85.
76. Navas C, Ortiz PL, Villuendas R, y cols. Genetics alterations in the p16/INK4A gene are frequent in lesions of mycosis fungoides. Am J Pathol 2000;156:1565-72.